-
If your clinical practice includes the care of age 50-plus women, are you including information on risks for sexually transmitted infections (STIs)? You should.
-
According to the Centers for Disease Control and Prevention, female adolescents have the highest number of cases of gonorrhea and chlamydia in the United States.1 While the overall prevalence for these infections among individuals ages 14-39 are .24% and 2.2% respectively, these rates are .92% and 3.4% for those ages 14-19.2
-
The Food and Drug Administration (FDA) has scheduled a Dec. 8, 2011, meeting of its Reproductive Health Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee to review the risks and benefits of oral contraceptives containing the progestin drospirenone. The agency is weighing evidence regarding the risk of increased blood clots in users of such pills.
-
Thyroid dysfunction and disease might present as reproductive compromise including oligomenorrhea, infertility, and miscarriage.
-
The safer sex message is reaching adolescents. Results of a new Centers for Disease Control and Prevention (CDC) report shows the percentage of teen males ages 15-19 in the United States who used a condom the first time they had sex increased between 2002 and 2006-2010.
-
The contraceptive options for women who cannot use hormonal methods might soon expand if regulatory approval is given to a new single-size diaphragm. Results of a two-year multi-site study of 450 U.S. couples indicate the effectiveness rates of the SILCS single size, contoured diaphragm, now in development, are similar to traditional diaphragms.
-
To perform the study, researchers designed a pooled analysis of individual data from two large studies by the International Agency for Research on Cancer, an international collaboration on cancer research, and the Institut Català d'Oncologia, a Spanish-based oncology research program.
-
In this issue: Apixaban could soon join the anticoagulation market; Chinese herbs for flu; chronic medication and discontinuation after hospitalization; and FDA actions.
-
In this case-control study, a well-established data-base of patients with interstitial cystitis/painful bladder syndrome (IC/PBS) was used to identify women with nocturia.
-